Russell Investments Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.8K Sell
2,558
-83
-3% -$1.16K ﹤0.01% 3060
2025
Q1
$35.9K Sell
2,641
-19,475
-88% -$265K ﹤0.01% 2978
2024
Q4
$451K Buy
22,116
+142
+0.6% +$2.89K ﹤0.01% 2302
2024
Q3
$640K Sell
21,974
-940
-4% -$27.4K ﹤0.01% 2196
2024
Q2
$532K Sell
22,914
-62,714
-73% -$1.46M ﹤0.01% 2175
2024
Q1
$1.76M Sell
85,628
-25,845
-23% -$530K ﹤0.01% 1711
2023
Q4
$2.39M Sell
111,473
-2,585
-2% -$55.5K ﹤0.01% 1517
2023
Q3
$2.35M Buy
114,058
+7,244
+7% +$149K ﹤0.01% 1456
2023
Q2
$3.15M Buy
106,814
+24,519
+30% +$724K 0.01% 1303
2023
Q1
$1.9M Sell
82,295
-17,078
-17% -$393K ﹤0.01% 1618
2022
Q4
$2.76M Sell
99,373
-7,488
-7% -$208K 0.01% 1389
2022
Q3
$3.28M Buy
106,861
+18,631
+21% +$571K 0.01% 1290
2022
Q2
$2.6M Buy
88,230
+36,710
+71% +$1.08M 0.01% 1447
2022
Q1
$1.66M Sell
51,520
-14,601
-22% -$469K ﹤0.01% 1729
2021
Q4
$2.95M Buy
66,121
+770
+1% +$34.4K ﹤0.01% 1586
2021
Q3
$3.28M Buy
65,351
+1,594
+3% +$80.1K 0.01% 1506
2021
Q2
$4.99M Buy
63,757
+15,791
+33% +$1.23M 0.01% 1354
2021
Q1
$2.73M Sell
47,966
-32,129
-40% -$1.83M ﹤0.01% 1709
2020
Q4
$6.71M Buy
80,095
+25,496
+47% +$2.14M 0.01% 1079
2020
Q3
$1.96M Hold
54,599
﹤0.01% 1703
2020
Q2
$1.32M Sell
54,599
-17,130
-24% -$414K ﹤0.01% 1886
2020
Q1
$1.26M Sell
71,729
-45,190
-39% -$791K ﹤0.01% 1732
2019
Q4
$2.04M Buy
116,919
+47,796
+69% +$832K ﹤0.01% 1731
2019
Q3
$1.06M Buy
69,123
+33,583
+94% +$515K ﹤0.01% 1980
2019
Q2
$736K Buy
35,540
+9,650
+37% +$200K ﹤0.01% 2116
2019
Q1
$601K Buy
25,890
+9,094
+54% +$211K ﹤0.01% 2282
2018
Q4
$347K Buy
+16,796
New +$347K ﹤0.01% 2435